The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Vinflunine maintenance therapy versus best supportive care after platinum combination in advanced bladder cancer: A phase II, randomized, open label, study (MAJA study, SOGUG 2011-02)—Interim analysis on safety.
Susana Hernando Polo
No relevant relationships to disclose
Aranzazu Gonzalez del Alba
No relevant relationships to disclose
Begoña Perez-Valderrama
No relevant relationships to disclose
José Carlos Villa Guzman
No relevant relationships to disclose
Miguel Angel Climent
No relevant relationships to disclose
Nuria Lainez
No relevant relationships to disclose
Albert Font
No relevant relationships to disclose
Ignacio Duran
No relevant relationships to disclose
Begoña Mellado
No relevant relationships to disclose
Daniel Castellano
No relevant relationships to disclose
Jesús García-Donas
No relevant relationships to disclose
Juan Antonio Virizuela
No relevant relationships to disclose
Luis Leon
No relevant relationships to disclose
Maria del Mar LLorente
No relevant relationships to disclose
Montserrat Domenech
No relevant relationships to disclose
Rafael Morales
No relevant relationships to disclose
Enrique Gallardo
No relevant relationships to disclose
Javier Puente
No relevant relationships to disclose
Sonia Maciá
No relevant relationships to disclose
Joaquim Bellmunt
No relevant relationships to disclose